Variant report

Variant	nsv881205
Chromosome Location	chr4:160516090-160628006
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:10)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:160581437..160584184-chr4:160604611..160607448,2	MCF-7	breast:
2	chr4:160590380..160592983-chr4:160712961..160714849,2	MCF-7	breast:
3	chr4:160588470..160591367-chr4:160593037..160595760,2	MCF-7	breast:
4	chr14:52541204..52541780-chr4:160517188..160517688,2	MCF-7	breast:
5	chr4:160606063..160608102-chr4:160627902..160629687,2	MCF-7	breast:
6	chr4:160583924..160586577-chr4:160586636..160588662,2	MCF-7	breast:
7	chr4:160581437..160584184-chr4:160604611..160607448,2	MCF-7	breast:
8	chr4:160588470..160591367-chr4:160593037..160595760,2	MCF-7	breast:
9	chr4:160583924..160586577-chr4:160586636..160588662,2	MCF-7	breast:
10	chr4:160606063..160608102-chr4:160627902..160629687,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-C4orf45-1	chr4:160587655-160587810	XLOC_004140

No data

Extended variants
information (count: 4539 )
Associated
traits (count: 78 )

Variant overlapped rSNPs/rCNVs (count:4539 , 50 per page) page: 1 2 3 4 5 6 7 ... 91

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs17239575	chr4:160516090-160516091	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs377351600	chr4:160516092-160516093	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs529514297	chr4:160516110-160516111	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs372282032	chr4:160516116-160516117	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs367839716	chr4:160516161-160516162	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs543018729	chr4:160516284-160516285	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs374079803	chr4:160516314-160516315	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs536299930	chr4:160516379-160516380	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs71609049	chr4:160516380-160516381	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs1827465	chr4:160516393-160516394	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs368063615	chr4:160516429-160516430	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs188986827	chr4:160516453-160516454	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs201311669	chr4:160516454-160516455	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs539386164	chr4:160516472-160516473	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs575409436	chr4:160516485-160516486	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs553298840	chr4:160516506-160516507	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs181509389	chr4:160516555-160516556	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs186484433	chr4:160516560-160516561	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs17038509	chr4:160516616-160516617	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs531256549	chr4:160516651-160516652	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs1393583	chr4:160516654-160516655	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs567333132	chr4:160516689-160516690	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs564445107	chr4:160516722-160516723	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs190851563	chr4:160516749-160516750	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs375216888	chr4:160516781-160516782	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs181081404	chr4:160516822-160516823	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs185918798	chr4:160516854-160516855	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs147935051	chr4:160516908-160516909	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs9998640	chr4:160516921-160516922	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs540720342	chr4:160516950-160516951	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs148375480	chr4:160516960-160516961	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs191562632	chr4:160516972-160516973	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs557330873	chr4:160516987-160516988	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs573102592	chr4:160516991-160516992	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs530928925	chr4:160517035-160517036	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs542669730	chr4:160517039-160517040	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs560714973	chr4:160517042-160517043	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs78226801	chr4:160517071-160517072	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs79669273	chr4:160517127-160517128	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs529492014	chr4:160517137-160517138	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs141790923	chr4:160517163-160517164	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs182907368	chr4:160517168-160517169	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs147083105	chr4:160517200-160517201	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs550853556	chr4:160517205-160517206	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs74551608	chr4:160517220-160517221	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs530014491	chr4:160517240-160517241	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs115155018	chr4:160517291-160517292	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs566820996	chr4:160517320-160517321	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs539147391	chr4:160517324-160517325	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs114018525	chr4:160517354-160517355	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:78)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
primary effusion lymphomas	17116491	CNVD
Breast cancer	16272173	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17133270	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Esophageal cancer	21851588	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Olfactory neuroblastoma	18408657	CNVD
Breast cancer	21785460	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	21633010	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20581869	CNVD
Myelofibrosis	22110671	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Glioblastoma multiforme	22286061	CNVD
Breast cancer	20409316	CNVD
Basal cell lymphoma	17053054	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	20164919	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	19805367	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Pancreatic cancer	17952125	CNVD
Schizophrenia	20967226	CNVD

Chromatin state (count:216 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:160508600-160526800	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
2	chr4:160513400-160517200	Enhancers	iPS-15b Cell Line	embryonic stem cell
3	chr4:160513400-160517400	Enhancers	HUES6 Cell Line	embryonic stem cell
4	chr4:160513600-160516800	Enhancers	iPS-20b Cell Line	embryonic stem cell
5	chr4:160513600-160517400	Enhancers	HUES48 Cell Line	embryonic stem cell
6	chr4:160513600-160517600	Enhancers	iPS-18 Cell Line	embryonic stem cell
7	chr4:160513800-160516200	Enhancers	Hela-S3	cervix
8	chr4:160513800-160517000	Enhancers	HUES64 Cell Line	embryonic stem cell
9	chr4:160514200-160516200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
10	chr4:160514200-160517400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
11	chr4:160514600-160517000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
12	chr4:160515000-160516400	Enhancers	ES-I3 Cell Line	embryonic stem cell
13	chr4:160515600-160516800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
14	chr4:160516000-160516600	Weak transcription	H1 Cell Line	embryonic stem cell
15	chr4:160516000-160519200	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
16	chr4:160516000-160519400	Weak transcription	H9 Cell Line	embryonic stem cell
17	chr4:160516200-160526800	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
18	chr4:160516400-160516800	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
19	chr4:160516600-160516800	Enhancers	H1 Cell Line	embryonic stem cell
20	chr4:160516800-160518800	Weak transcription	H1 Cell Line	embryonic stem cell
21	chr4:160516800-160519200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
22	chr4:160516800-160520000	Enhancers	ES-I3 Cell Line	embryonic stem cell
23	chr4:160516800-160530000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
24	chr4:160517000-160517400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
25	chr4:160517000-160518600	Weak transcription	HUES64 Cell Line	embryonic stem cell
26	chr4:160517200-160517600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
27	chr4:160517400-160517800	Weak transcription	HUES6 Cell Line	embryonic stem cell
28	chr4:160517400-160518800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
29	chr4:160517400-160518800	Weak transcription	HUES48 Cell Line	embryonic stem cell
30	chr4:160517400-160519200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
31	chr4:160517600-160517800	Enhancers	iPS-15b Cell Line	embryonic stem cell
32	chr4:160517600-160518000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
33	chr4:160517800-160518000	Enhancers	HUES6 Cell Line	embryonic stem cell
34	chr4:160517800-160519200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
35	chr4:160518000-160518200	Enhancers	iPS-18 Cell Line	embryonic stem cell
36	chr4:160518000-160519200	Weak transcription	HUES6 Cell Line	embryonic stem cell
37	chr4:160518200-160519200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
38	chr4:160518600-160519800	Enhancers	HUES64 Cell Line	embryonic stem cell
39	chr4:160518800-160519600	Enhancers	H1 Cell Line	embryonic stem cell
40	chr4:160518800-160519600	Enhancers	HUES48 Cell Line	embryonic stem cell
41	chr4:160518800-160520000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
42	chr4:160519200-160519400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
43	chr4:160519200-160519600	Enhancers	HUES6 Cell Line	embryonic stem cell
44	chr4:160519200-160519600	Enhancers	iPS-18 Cell Line	embryonic stem cell
45	chr4:160519200-160519800	Enhancers	iPS-20b Cell Line	embryonic stem cell
46	chr4:160519200-160520000	Enhancers	iPS-15b Cell Line	embryonic stem cell
47	chr4:160519200-160520400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
48	chr4:160519200-160521400	Active TSS	Fetal Kidney	kidney
49	chr4:160519400-160519600	Enhancers	H9 Cell Line	embryonic stem cell
50	chr4:160519600-160527600	Weak transcription	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links